UCSF

ZINC03927198

Substance Information

In ZINC since Heavy atoms Benign functionality
October 20th, 2005 26 No

CAS Numbers: 91832-40-5 , [91832-40-5]

Other Names:

(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime

(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl) (hydroxyimino)acetyl)amino)-3-eth

(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl) (hydroxyimino)acetyl)amino)-3-ethenyl-8-oxo-, (6R-(6alpha,7beta(Z)))-

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(hydroxyiminoacetyl)amino)-3-ethenyl-8-oxo-, (6R-(6-alpha,7-beta(Z)))-

7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid

7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid

91832-40-5

91832-40-5; C08110; Cefdinir

91832-40-5; CFDN; Cefdinir (JP16/USAN/INN); Cefzon (TN); D00917; Omnicef (TN)

AC1OCD3C

BIDD:GT0827

BMY 28488

BRD-K15766189-001-05-6

BSPBio_002735

C08110

C14H13N5O5S2

cef-

Cefdinir (BAN

Cefdinir (JP15/USAN/INN)

Cefdinir (Omnicef)

Cefdinir [USAN:INN]

cefdinir; cefdinirum

CEFDINIR; CPD000469224; SAM001246818

Cefdinirum

Cefdinirum [INN-Latin]

Cefdinyl

Cefdirnir

Cefdirnir;CFDN

Cefzon

Cefzon (TN)

CFDN

CHEBI:184624

CHEBI:3485

CHEMBL927

CI 983

CI-983

CI-983; FK-482

CID6915944

CPD000469224; CEFDINIR

CPD000469224; SAM001246818; cefdinir

D00917

DAP000436

DB00535

FDA

FK 482

FK-482

FK-482, BMY-28488, PD 134393, CI-983

FR-80482

HMS1922L19

HMS2093K20

INN

KS-1038

LS-149988

MFCD00865030

MolPort-002-885-812

NCGC00178499-01

Omnicef

Omnicef (TN)

Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir

PD 134393

PD-134393

S1605_Selleck

SPECTRUM1505208

Spectrum5_001560

ST-7387

UNII-CI0FAO63WC

USAN)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -0.57 2.89 -71.41 4 10 -1 161 394.414 5
Hi High (pH 8-9.5) -0.57 4.15 -131.62 3 10 -2 164 393.406 5

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 8.78e-02 g/l DrugBank-approved
Purity 97% Fluorochem
Therapy antibacterial SMDC Iconix
Indications antibiotic KeyOrganics Bioactives
Target Antifection Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP018855c NIH Clinical Collection via PubChem
Target Others Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP018855c NIH Clinical Collection via PubChem

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )